Your browser doesn't support javascript.
loading
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1).
Janssen, Boris V; van Roessel, Stijn; van Dieren, Susan; de Boer, Onno; Adsay, Volkan; Basturk, Olca; Brosens, Lodewijk; Campbell, Fiona; Chatterjee, Deyali; Chou, Angela; Doglioni, Claudio; Esposito, Irene; Feakins, Roger; Fuchs, Talia L; Fukushima, Noriyoshi; Gill, Anthony J; Hong, Seung-Mo; Hruban, Ralph H; Kaplan, Jeffrey; Krasinkas, Alyssa; Luchini, Claudio; Shi, Chanjuan; Singhi, Aatur; Thompson, Elizabeth; Velthuysen, Marie-Louise F; Besselink, Marc G; Verheij, Joanne; Wang, Huamin; Verbeke, Caroline; Fariña, Arantza.
Afiliação
  • Janssen BV; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • van Roessel S; Department of Pathology, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • van Dieren S; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • de Boer O; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Adsay V; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Basturk O; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Brosens L; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Campbell F; Department of Pathology, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
  • Chatterjee D; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Chou A; Department of Pathology, Koc University and KUTTAM Research Centre, Istanbul, Turkey.
  • Doglioni C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Esposito I; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Feakins R; Department of Pathology, Royal Liverpool University Hospital, Liverpool, UK.
  • Fuchs TL; Department of Anatomical Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fukushima N; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, and University of Sydney, Sydney, New South WalesAustralia.
  • Gill AJ; Department of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Hong SM; Institute of Pathology, Heinrich-Heine-University and University Hospital of Duesseldorf, Duesseldorf, Germany.
  • Hruban RH; Department of Pathology, Royal Free London NHS Trust, London, UK.
  • Kaplan J; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, and University of Sydney, Sydney, New South WalesAustralia.
  • Krasinkas A; Department of Pathology, Jichi Medical University Hospital, Tochigi, Japan.
  • Luchini C; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, and University of Sydney, Sydney, New South WalesAustralia.
  • Shi C; Department of Pathology, Asan Medical Centre, Seoul, Korea.
  • Singhi A; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Thompson E; Department of Pathology, University of Colorado Hospital, Denver, Colorado, USA.
  • Velthuysen MF; Department of Pathology, Emory University, Atlanta, Georgia, USA.
  • Besselink MG; Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
  • Verheij J; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
  • Wang H; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Verbeke C; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Fariña A; Department of Pathology, Erasmus Medical Centre, Rotterdam, the Netherlands.
Br J Surg ; 110(1): 67-75, 2022 12 13.
Article em En | MEDLINE | ID: mdl-36331867

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article